K. U. Weithmann

670 total citations
19 papers, 540 citations indexed

About

K. U. Weithmann is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, K. U. Weithmann has authored 19 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in K. U. Weithmann's work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Peptidase Inhibition and Analysis (5 papers) and Protease and Inhibitor Mechanisms (5 papers). K. U. Weithmann is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Peptidase Inhibition and Analysis (5 papers) and Protease and Inhibitor Mechanisms (5 papers). K. U. Weithmann collaborates with scholars based in Germany, United States and Canada. K. U. Weithmann's co-authors include K. Ulrich Wendt, Alex Sevanian, Paul Hochstein, Reinhard Kirsch, Jörg Habermann, Bernard Pirard, Christian K. Engel, Otmar Klingler, D. Seiffge and Hans Matter and has published in prestigious journals such as Biochemical Journal, Free Radical Biology and Medicine and Journal of Medicinal Chemistry.

In The Last Decade

K. U. Weithmann

19 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. U. Weithmann Germany 11 223 210 186 71 67 19 540
Maria Valentine United States 11 201 0.9× 102 0.5× 78 0.4× 81 1.1× 53 0.8× 13 694
Yongdong Niu China 16 414 1.9× 159 0.8× 222 1.2× 29 0.4× 22 0.3× 43 890
C. Dachet France 12 183 0.8× 187 0.9× 74 0.4× 52 0.7× 18 0.3× 21 649
Graziella Malaponte Italy 9 241 1.1× 67 0.3× 125 0.7× 22 0.3× 47 0.7× 10 481
Dean J. Welsch United States 13 313 1.4× 188 0.9× 158 0.8× 117 1.6× 44 0.7× 22 686
Yoshiki Amuro Japan 17 341 1.5× 87 0.4× 222 1.2× 19 0.3× 44 0.7× 52 735
Motohiro Yamamori Japan 18 252 1.1× 103 0.5× 212 1.1× 64 0.9× 22 0.3× 42 655
Devendra K. Vora United States 10 390 1.7× 95 0.5× 70 0.4× 54 0.8× 25 0.4× 10 1.0k
Denis McCann United States 15 566 2.5× 63 0.3× 149 0.8× 25 0.4× 85 1.3× 26 826
James A. Koehn United States 14 262 1.2× 87 0.4× 182 1.0× 81 1.1× 20 0.3× 24 668

Countries citing papers authored by K. U. Weithmann

Since Specialization
Citations

This map shows the geographic impact of K. U. Weithmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. U. Weithmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. U. Weithmann more than expected).

Fields of papers citing papers by K. U. Weithmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. U. Weithmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. U. Weithmann. The network helps show where K. U. Weithmann may publish in the future.

Co-authorship network of co-authors of K. U. Weithmann

This figure shows the co-authorship network connecting the top 25 collaborators of K. U. Weithmann. A scholar is included among the top collaborators of K. U. Weithmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. U. Weithmann. K. U. Weithmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Caglič, Dejan, Maik Kindermann, Ngee Han Lim, et al.. (2010). Functional in vivo imaging of cysteine cathepsin activity in murine model of inflammation. Bioorganic & Medicinal Chemistry. 19(3). 1055–1061. 38 indexed citations
2.
Engel, Christian K., Bernard Pirard, Reinhard Kirsch, et al.. (2005). Structural Basis for the Highly Selective Inhibition of MMP-13. Chemistry & Biology. 12(2). 181–189. 174 indexed citations
3.
Matter, Hans, Wilfried Schwab, Bernhard Neises, et al.. (1999). Quantitative Structure−Activity Relationship of Human Neutrophil Collagenase (MMP-8) Inhibitors Using Comparative Molecular Field Analysis and X-ray Structure Analysis. Journal of Medicinal Chemistry. 42(11). 1908–1920. 59 indexed citations
4.
Sevanian, Alex, et al.. (1998). Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein in vitro. Free Radical Biology and Medicine. 25(7). 839–847. 78 indexed citations
5.
Orgel, Dagmar, et al.. (1998). The Cleavage of Pro-Urokinase Type Plasminogen Activator by Stromelysin-1. Clinical Chemistry and Laboratory Medicine (CCLM). 36(9). 697–702. 14 indexed citations
6.
Weithmann, K. U., et al.. (1997). Effects of tiaprofenic acid on urinary pyridinium crosslinks in adjuvant arthritic rats: Comparison with doxycycline. Inflammation Research. 46(7). 246–252. 5 indexed citations
7.
Weithmann, K. U., et al.. (1994). Effect of leflunomide on constitutive and inducible pathways of cellular eicosanoid generation. Inflammation Research. 41(3-4). 164–170. 28 indexed citations
8.
Bartlett, R. R., et al.. (1990). Pharmacological profile of HWA-131, a novel antiinflammatory agent with immunomodulating properties. Inflammation Research. 29(1-2). 71–73. 10 indexed citations
9.
Römisch, Jürgen, Mathias Grote, K. U. Weithmann, N. Heimburger, & Egon Amann. (1990). Annexin proteins PP4 and PP4-X. Comparative characterization of biological activities of placental and recombinant proteins. Biochemical Journal. 272(1). 223–229. 20 indexed citations
10.
Seiffge, D. & K. U. Weithmann. (1989). Update on the Pharmacology of Pentoxifylline and Its Combination with Low-Dose Acetylsalicyclic Acid (HWA 5112). Seminars in Thrombosis and Hemostasis. 15(2). 150–158. 7 indexed citations
11.
Weithmann, K. U., et al.. (1989). Stimulatory effects of vascular prostaglandins on the antiaggregatory activities of pentoxifylline acetylsalicylic acid combinations in vitro.. PubMed. 18(4). 273–6. 2 indexed citations
12.
Weithmann, K. U., Hazel Peterson, & Alex Sevanian. (1989). Incorporation of arachidonic, dihomogamma linolenic and eicosapentaenoic acids into cultured V79 cells. Lipids. 24(3). 173–178. 11 indexed citations
13.
Seiffge, D. & K. U. Weithmann. (1987). Superadditive antithrombotic effects follow consecutive administration of drugs. European Journal of Pharmacology. 137(2-3). 287–288. 2 indexed citations
14.
Schmidt, D., et al.. (1985). Hochempfindliche GC/MS-Methode zur Bestimmung des stabilen Prostacyclin Metaboliten 6-oxo-PGF1α in Humanurin. Fresenius Zeitschrift für Analytische Chemie. 320(7). 732–732. 3 indexed citations
15.
Weithmann, K. U.. (1983). Reduced platelet aggregation by effects of pentoxifylline on vascular prostacyclin isomerase and platelet cyclic AMP. General Pharmacology The Vascular System. 14(1). 161–162. 13 indexed citations
16.
Weithmann, K. U.. (1982). Effect of furosemide on prostacyclin-like antiaggregatory release from vessel wall and renal cortex. Pharmacological Research Communications. 14(5). 391–399. 1 indexed citations
17.
Weithmann, K. U., et al.. (1982). HL 725, an extremely potent inhibitor of platelet phosphodiesterase and induced platelet aggregation in vitro. Life Sciences. 31(19). 2037–2043. 67 indexed citations
18.
19.
Weithmann, K. U., et al.. (1978). A modified assay system for collagen glucosyltransferase. Diabetologia. 15(2). 125–128. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Valentine Breakdown of academic impact, for papers by Yongdong Niu Breakdown of academic impact, for papers by C. Dachet Breakdown of academic impact, for papers by Graziella Malaponte Breakdown of academic impact, for papers by Dean J. Welsch Breakdown of academic impact, for papers by Yoshiki Amuro Breakdown of academic impact, for papers by Motohiro Yamamori Breakdown of academic impact, for papers by Devendra K. Vora Breakdown of academic impact, for papers by Denis McCann Breakdown of academic impact, for papers by James A. Koehn
Rankless by CCL
2026